Clinical Trial Update: Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase II trial evaluating the V-BEAM conditioning regimen before a second autologous stem cell transplantation in multiple myeloma was terminated, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Carmustine (carmustine)
• Etoposide (Etoposide)
• Melphalan (Melphalan)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2014-10-15